• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiviral Res . Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues

tetano

Editor, Senior Moderator
Antiviral Res


. 2021 Jul 1;105127.
doi: 10.1016/j.antiviral.2021.105127. Online ahead of print.
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues


Leentje Persoons[SUP] 1 [/SUP], Evelien Vanderlinden[SUP] 2 [/SUP], Laura Vangeel[SUP] 1 [/SUP], Xinyu Wang[SUP] 1 [/SUP], Nguyen Dan Thuc Do[SUP] 1 [/SUP], Shi-Yan Caroline Foo[SUP] 1 [/SUP], Pieter Leyssen[SUP] 1 [/SUP], Johan Neyts[SUP] 1 [/SUP], Dirk Jochmans[SUP] 1 [/SUP], Dominique Schols[SUP] 1 [/SUP], Steven De Jonghe[SUP] 1 [/SUP]



Affiliations

Abstract

In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC[SUB]50[/SUB] values in the range of 0.12-12 μM. Chloroquine displayed the most favorable selectivity index (i.e. ratio cytotoxic versus antiviral concentration), being 165 for HCoV-OC43 in HEL cells. Potent anti-coronavirus activity was also observed with amodiaquine, ferroquine and mefloquine, although this was associated with substantial cytotoxicity for mefloquine. Primaquine, quinidine, quinine and tafenoquine only blocked coronaviruses replication at higher concentrations, while piperaquine completely lacked antiviral and cytotoxic effect. A time-of-addition experiment in HCoV-229E-infected HEL cells revealed that chloroquine interferes with viral entry at a post-attachment stage. Using confocal microscopy, no viral RNA synthesis could be detected upon treatment of SARS-CoV-2-infected cells with chloroquine. The inhibition of SARS-CoV-2 replication by chloroquine and hydroxychloroquine coincided with an inhibitory effect on the autophagy pathway as visualized by a dose-dependent increase in LC3-positive puncta. The latter effect was less pronounced or even absent with the other quinolines. In summary, we showed that several quinoline analogues, including chloroquine, hydroxychloroquine, amodiaquine, ferroquine and mefloquine, exhibit broad anti-coronavirus activity in vitro.

Keywords: Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline.
 
Back
Top Bottom